PMV Pharma FY 2024 GAAP EPS $(1.14) Misses $(1.08) Estimate
Benzinga Newsdesk 1 year ago
EarningsNews
PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.08) by 5.56 percent.
PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.08) by 5.56 percent.